Advertisement
Advertisement

ARDT

ARDT logo

Ardent Health, Inc.

8.60
USD
Sponsored
-0.30
-3.43%
Jan 16, 15:59 UTC -5
Closed
exchange

After-Market

8.82

+0.22
+2.62%

ARDT Earnings Reports

Positive Surprise Ratio

ARDT beat 5 of 6 last estimates.

83%

Next Report

Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.66B
/
$0.32
Implied change from Q3 25 (Revenue/ EPS)
+5.59%
/
-38.46%
Implied change from Q4 24 (Revenue/ EPS)
+3.64%
/
-60.49%

Ardent Health, Inc. earnings per share and revenue

On Nov 12, 2025, ARDT reported earnings of 0.52 USD per share (EPS) for Q3 25, beating the estimate of 0.41 USD, resulting in a 24.85% surprise. Revenue reached 1.58 billion, compared to an expected 1.58 billion, with a -0.11% difference. The market reacted with a -33.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of 0.32 USD, with revenue projected to reach 1.66 billion USD, implying an decrease of -38.46% EPS, and increase of 5.59% in Revenue from the last quarter.
FAQ
For Q3 2025, Ardent Health, Inc. reported EPS of $0.52, beating estimates by 24.85%, and revenue of $1.58B, -0.11% below expectations.
The stock price moved down -33.81%, changed from $14.05 before the earnings release to $9.30 the day after.
The next earning report is scheduled for Feb 24, 2026.
Based on 14 analysts, Ardent Health, Inc. is expected to report EPS of $0.32 and revenue of $1.66B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement